Select Page

TECHNOLOGY

LEADERSHIP

ADVISORS

BOARD

CONTACT

TECHNOLOGY

ECM Biosurgery is focused on the application of a proprietary technology platform, Designer Collagens, to develop a portfolio of products to address surgical needs in human and animal health. 

ECM Biosurgery portfolio of biosurgery products will address a $2-3 billion market potential across General, Plastic & Reconstructive, Cardiovascular, and Gynecology surgery.

LEADERSHIP

David McQuillan, PhD

CEO

David is an expert in medical devices and regenerative medicine (product development, business development, IP, corporate strategy). 

Magnus Hook, PhD

CSO

Magnus is an internationally recognized expert in bacterial pathogenesis and ECM biology. He has published more than 200 scientific papers and is inventor on more than 30 patents.

Brooke Russell, PhD

Vice President

Brooke is trained in medical sciences and is co-founder of ECM Biosurgery. As VP, she manages operational activities.

Canaan Whitfield, DVM

Vice President, Animal Health

Canaan manages an active research program in equine surgical practice, wound healing, and infectious disease.

 

ADVISORS

Noah Cohen, PhD, MPH, VMD

Associate Department Head and Professor Large Animal Internal Medicine, Texas A&M University

Greg Schultz, PhD

Professor of Obstetrics and Gynecology, University of Florida

Charles Butler, MD, FACS

Charles B. Barker Chair in Surgery, Department of Plastic Surgery, Division of Surgery, MD Anderson Cancer Center

Elizabeth Cosgriff-Hernandez, PhD

Professor of Biomedical Engineering, University of Texas

Eddy J Rogers, Counsel

BOARD OF DIRECTORS

Magnus Hook, PhD

Chairman

Larry Lawson

David McQuillan, PhD

Joseph Patti, Ph.D.

Jed Rogers, DVM

John Untereker